<DOC>
	<DOCNO>NCT01648517</DOCNO>
	<brief_summary>This prospective phase II trial , patient unresectable metastatic NSCLC use chemotherapy regimen define accord mRNA expression ERCC1 RRM1 tumor cell .</brief_summary>
	<brief_title>Genotype-Driven Treatment Advanced Non-small Cell Lung Cancer Based mRNA Expression ERCC1 &amp; RRM1 First-line Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>1 . Histologically confirm unresectable advanced metastatic nonsmall cell lung cancer ( NSCLC ) ( stage IIIB IV ) 2 . Chemotherapy naïve patient ( Previous adjuvant neoadjuvant chemotherapy allow last dose administer equal great 6 month ago . ) 3 . Age &gt; 18 4 . Performance status 0 2 Eastern Cooperative Oncology Group ( ECOG ) criteria 5 . At least one measurable lesion Response Evaluation Criteria In Solid Tumors ( RECIST ) 6 . Adequate organ function ( assess within 14 day start treatment ) 1 ) Bone marrow : Absolute neutrophil count ≥ 1,500/mm³ , Platelet count ≥ 100,000/mm³ , Hemoglobin ≥ 9.0 mg/dL 2 ) Liver : Total bilirubin ≤ 1.5 x ULN ; aspartic transaminase ( AST ) alanine transaminase ( ALT ) , alkaline phosphatase ( ALP ) ≤ 2.5 x ULN 3 ) Kidney : Serum creatinine ≤ 1.5 x ULN 7 . Signed informed consent document 1 . Clinically significant serious illness medical condition ( infection ) 2 . Prior systemic chemotherapy immunotherapy advance NSCLC . 3 . Presence uncontrolled brain leptomeningeal metastases 4 . Prior radiotherapy within 3 week start treatment 5 . Peripheral neuropathy equal great grade 2 Common Terminology Criteria Adverse Events ( CTCAE ) v4.0 6 . Pregnant lactate 7 . Absolute contraindication corticosteroid use 8 . Patients history severe hypersensitivity reaction docetaxel , carboplatin , vinorelbine gemcitabine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>on-small cell lung carcinoma</keyword>
	<keyword>chemotherapy naive patient</keyword>
</DOC>